Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Zosano Pharma Corporation ZSANQ

Healthcare Biotechnology

Zosano Pharma Corp is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Zosano Pharma Corp is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K... see more

Add To Watchlist

Recent & Breaking News (EXPM:ZSANQ)

Zosano Pharma Reports First Quarter 2019 Financial Results

GlobeNewswire May 14, 2019

Zosano Announces Full Exercise of Underwriter's Option to Purchase Additional Shares

GlobeNewswire May 9, 2019

Zosano Pharma to Host Conference Call on First Quarter 2019 Financial Results and Provide Operational Update

GlobeNewswire May 8, 2019

Mid-Afternoon Market Update: Dow Down Over 200 Points; Precipio Shares Spike Higher

Benzinga.com April 9, 2019

Mid-Day Market Update: Command Center Surges Following Merger Deal With Hire Quest; Hollysys Automation Shares Slide

Benzinga.com April 9, 2019

Mid-Morning Market Update: Markets Open Lower; PhaseBio Gets Breakthrough Therapy Designation For PB2452

Benzinga.com April 9, 2019

Zosano Announces Pricing of Public Offering of Common Stock

GlobeNewswire April 9, 2019

6 Stocks To Watch For April 9, 2019

Benzinga.com April 9, 2019

Zosano Pharma Announces Proposed Public Offering of Common Stock

GlobeNewswire April 8, 2019

Zosano Pharma Reports Fourth Quarter and Fiscal Year 2018 Financial Results

Business Wire March 14, 2019

Zosano Pharma Announces Presentation and Participation at the 31st Annual Roth Conference

GlobeNewswire March 11, 2019

Zosano Pharma to Host Conference Call on Fourth Quarter and Full Year 2018 Financial Results and Provide Operational and Strategic Update

GlobeNewswire March 7, 2019

Thinking about buying stock in Apple, Canopy Growth Corp, Immune Design, Roku Inc or Zosano Pharma?

PR Newswire February 22, 2019

Mid-Afternoon Market Update: Dow Falls 150 Points; Delphi Technologies Shares Spike Higher

Benzinga.com February 21, 2019

Mid-Day Market Update: Immune Design Jumps Following Acquisition News; Carbon Black Shares Slide

Benzinga.com February 21, 2019

Mid-Morning Market Update: Markets Open Lower; Domino's Pizza Misses Q4 Views

Benzinga.com February 21, 2019

Zosano Announces Completion of the Final Milestone in the Long-Term Safety Study of Qtrypta™ for the Acute Treatment of Migraine Disease

GlobeNewswire February 21, 2019

Zosano Announces Publication of Positive Data on Qtrypta’s™ Potential as an Acute Treatment for Patients with Difficult-to-Treat Migraines

GlobeNewswire January 31, 2019

Zosano Appoints Linda Grais M.D., J.D. to Board of Directors

GlobeNewswire January 16, 2019

Zosano Receives Conditional FDA Acceptance of Proposed Brand Name Qtrypta™ for M207

GlobeNewswire December 12, 2018